Study of IMC-EB10 in Participant With Leukemia
Clinical trial NCT00887926 · TERMINATED
Trial details
- NCT number
- NCT00887926
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.